Trials / Completed
CompletedNCT03648008
Postoperative Analgesic Effect of Hydromorphone on Partial Pulmonary Resection Under Video-assisted Thoracoscopy
Postoperative Analgesic Effect of Hydromorphone on Chinese Patients Receiving Partial Pulmonary Resection Under Video-assisted Thoracoscopy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 171 (actual)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Postoperative pain remains relatively high within 48h for Chinese patients who receive video-assisted thoracoscopic surgery. Multimodal analgesia combines several agents and/or techniques to function on diverse nociceptive mechanisms to enhance pain relief and lessen side effect. Hydromorphone is a hydrogenated ketone of morphine and approximately 5-10 times more potent. There lacks about efficacy and efficiency of hydromorphone in electrical pump for patient controlled intravenous analgesic (PCIA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydromorphone | 0.002 mg\*kg-1 bolus with 0.002 mg\*kg-1 background infusion for group BH 0.002 mg\*kg-1 bolus without background infusion for group NBH Drug is administered through PCIA pump. |
| DRUG | Morphine | 0.015 mg\*kg-1 bolus without background infusion for group M Drug is administered through PCIA pump. |
Timeline
- Start date
- 2018-05-05
- Primary completion
- 2018-09-01
- Completion
- 2018-09-01
- First posted
- 2018-08-27
- Last updated
- 2018-09-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03648008. Inclusion in this directory is not an endorsement.